Litigation Details for FWK Holdings, LLC v. Novartis Pharmaceuticals Corporation (S.D.N.Y. 2018)
✉ Email this page to a colleague
FWK Holdings, LLC v. Novartis Pharmaceuticals Corporation (S.D.N.Y. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-06-29 |
Court | District Court, S.D. New York | Date Terminated | |
Cause | 15:2 Antitrust Litigation | Assigned To | Alvin K. Hellerstein |
Jury Demand | Plaintiff | Referred To | |
Patents | 6,294,197; 6,395,728 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in FWK Holdings, LLC v. Novartis Pharmaceuticals Corporation
Details for FWK Holdings, LLC v. Novartis Pharmaceuticals Corporation (S.D.N.Y. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-06-29 | 1 | Complaint | .S. Patent No. 6,294,197 (the “‘197 Patent,” which expired on June 18, 2017); and (3) U.S. Patent No.…: (1) the ‘578 Patent; (2) the ‘197 Patent; and (3) the ‘728 Patent. The ‘578 Patent, which disclosed…three Novartis patents listed for Exforge: (1) U.S. Patent No. 5,399,578 (the “‘578 Patent” which expired…date of the ’728 Patent. The patent application that issued as the ‘904 Prior Art Patent was filed on July…Prior Art Patent. b. The ‘197 Patent No valid claim of the ‘197 Patent was infringed | External link to document |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |